BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xue LJ, Yang XZ, Tong Q, Shen P, Ma SJ, Wu SN, Zheng JL, Wang HG. Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study. Medicine (Baltimore) 2020;99:e22035. [PMID: 32871960 DOI: 10.1097/MD.0000000000022035] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Pereira NRM, Naufel MF, Tufik S, Hachul H. Do food and sleep quality interfere with Parkinson's disease? Ir J Med Sci 2023. [PMID: 36715791 DOI: 10.1007/s11845-023-03292-y] [Reference Citation Analysis]
2 Liang S, Wang L, Wu X, Hu X, Wang T, Jin F. The different trends in the burden of neurological and mental disorders following dietary transition in China, the USA, and the world: An extension analysis for the Global Burden of Disease Study 2019. Front Nutr 2022;9:957688. [PMID: 36698474 DOI: 10.3389/fnut.2022.957688] [Reference Citation Analysis]
3 Matheson JT, Holsinger RMD. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review. Int J Mol Sci 2023;24. [PMID: 36674517 DOI: 10.3390/ijms24021001] [Reference Citation Analysis]
4 Lin CH, Lai HC, Wu MS. Gut-oriented disease modifying therapy for Parkinson's disease. J Formos Med Assoc 2023;122:9-18. [PMID: 36182642 DOI: 10.1016/j.jfma.2022.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Kobyliak N. Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option. Microbiome in 3P Medicine Strategies 2023. [DOI: 10.1007/978-3-031-19564-8_10] [Reference Citation Analysis]
6 Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options. J Parkinsons Dis 2022;12:2339-52. [PMID: 36278360 DOI: 10.3233/JPD-223461] [Reference Citation Analysis]
7 Papić E, Rački V, Hero M, Tomić Z, Starčević-Čižmarević N, Kovanda A, Kapović M, Hauser G, Peterlin B, Vuletić V. The effects of microbiota abundance on symptom severity in Parkinson's disease: A systematic review. Front Aging Neurosci 2022;14:1020172. [PMID: 36570528 DOI: 10.3389/fnagi.2022.1020172] [Reference Citation Analysis]
8 Soraci L, Gambuzza ME, Biscetti L, Laganà P, Lo Russo C, Buda A, Barresi G, Corsonello A, Lattanzio F, Lorello G, Filippelli G, Marino S. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications. J Neurol 2022. [DOI: 10.1007/s00415-022-11491-3] [Reference Citation Analysis]
9 Mitra S, Dash R, Al Nishan A, Ummey Habiba S, Soo Moon I. Brain modulation by the gut microbiota: from disease to therapy. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.12.001] [Reference Citation Analysis]
10 Wei W, Wang S, Xu C, Zhou X, Lian X, He L, Li K. Gut microbiota, pathogenic proteins and neurodegenerative diseases. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.959856] [Reference Citation Analysis]
11 Salim S, Ahmad F, Banu A, Mohammad F. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.10.013] [Reference Citation Analysis]
12 Iannone LF, Gómez-eguílaz M, De Caro C. Gut microbiota manipulation as an epilepsy treatment. Neurobiology of Disease 2022;174:105897. [DOI: 10.1016/j.nbd.2022.105897] [Reference Citation Analysis]
13 Varesi A, Campagnoli LIM, Fahmideh F, Pierella E, Romeo M, Ricevuti G, Nicoletta M, Chirumbolo S, Pascale A. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment. Int J Mol Sci 2022;23:12289. [PMID: 36293176 DOI: 10.3390/ijms232012289] [Reference Citation Analysis]
14 Dowling LR, Strazzari MR, Keely S, Kaiko GE. Enteric nervous system and intestinal epithelial regulation of the gut-brain axis. J Allergy Clin Immunol 2022;150:513-22. [PMID: 36075637 DOI: 10.1016/j.jaci.2022.07.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Gernone F, Uva A, Silvestrino M, Cavalera MA, Zatelli A. Role of Gut Microbiota through Gut–Brain Axis in Epileptogenesis: A Systematic Review of Human and Veterinary Medicine. Biology 2022;11:1290. [DOI: 10.3390/biology11091290] [Reference Citation Analysis]
16 Zeng J, Wang X, Pan F, Mao Z. The relationship between Parkinson’s disease and gastrointestinal diseases. Front Aging Neurosci 2022;14:955919. [DOI: 10.3389/fnagi.2022.955919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dinan K, Dinan TG. Gut Microbes and Neuropathology: Is There a Causal Nexus? Pathogens 2022;11:796. [DOI: 10.3390/pathogens11070796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ghezzi L, Cantoni C, Rotondo E, Galimberti D. The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases. Biomedicines 2022;10:1486. [PMID: 35884791 DOI: 10.3390/biomedicines10071486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Cheng WY, Ho YS, Chang RC. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases. Ageing Res Rev 2022;78:101620. [PMID: 35405323 DOI: 10.1016/j.arr.2022.101620] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
21 Vendrik KE, Bekker-chernova VO, Kuijper EJ, Terveer EM, van Hilten JJ, Contarino MF. Safety and feasibility of fecal microbiota transplantation for Parkinson’s disease patients: a protocol for a self-controlled interventional donor-FMT pilot study.. [DOI: 10.1101/2022.05.23.22274942] [Reference Citation Analysis]
22 Ciliberti MG, Santillo A, Polito R, Messina G, Albenzio M. The Role of Milk Nutrition and Ketogenic Diet in Epileptic Disorders. Epilepsy 2022. [DOI: 10.36255/exon-publications-epilepsy-ketogenic-diet] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Halaweish HF, Boatman S, Staley C. Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application. Front Cell Infect Microbiol 2022;12:826114. [DOI: 10.3389/fcimb.2022.826114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Hrncir T. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms 2022;10:578. [DOI: 10.3390/microorganisms10030578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sze C, Pressler M, Lee JR, Chughtai B. The gut, vaginal, and urine microbiome in overactive bladder: a systematic review. Int Urogynecol J 2022. [PMID: 35237854 DOI: 10.1007/s00192-022-05127-3] [Reference Citation Analysis]
26 Núñez F. P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterología y Hepatología (English Edition) 2022;45:223-230. [DOI: 10.1016/j.gastre.2021.05.005] [Reference Citation Analysis]
27 Diez-ozaeta I, Juaristi Astiazaran O. Fermented foods: an update on evidence-based health benefits and future perspectives. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
28 Hang Z, Cai S, Lei T, Zhang X, Xiao Z, Wang D, Li Y, Bi W, Yang Y, Deng S, Wang L, Li Q, Du H. Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer's Disease Mice. J Alzheimers Dis 2022. [PMID: 35180124 DOI: 10.3233/JAD-215495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Haindl R, Totzauer L, Kulozik U. Preservation by lyophilization of a human intestinal microbiota: influence of the cultivation pH on the drying outcome and re‐establishment ability. Microbial Biotechnology. [DOI: 10.1111/1751-7915.14007] [Reference Citation Analysis]
30 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2022;37:246-55. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Liebert A, Bicknell B, Laakso EL, Jalilitabaei P, Tilley S, Kiat H, Mitrofanis J. Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19. Photobiomodul Photomed Laser Surg 2022;40:112-22. [PMID: 34919459 DOI: 10.1089/photob.2021.0056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, Scarpellini E, Kobyliak N, Abenavoli L. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina (Kaunas) 2022;58:84. [PMID: 35056392 DOI: 10.3390/medicina58010084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
34 Neuman H, Turjeman S, Koren O. The Gut Microbiome. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00040-7] [Reference Citation Analysis]
35 Cabré S, O’riordan KJ, Cryan JF. Neurodegenerative Diseases and the Gut Microbiota. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis 2022. [DOI: 10.1007/978-3-030-91051-8_11] [Reference Citation Analysis]
36 I. V. Litvinenko, V. Yu. Lobzin. On a New Paradigm of the Development of Neurodegenerative Diseases by the Example of Alzheimer’s Disease and Parkinson’s Disease. Adv Gerontol 2022;12. [ DOI: 10.1134/S2079057022040117] [Reference Citation Analysis]
37 Edwards V, Smith DL, Meylan F, Tiffany L, Poncet S, Wu WW, Phue JN, Santana-Quintero L, Clouse KA, Gabay O. Analyzing the Role of Gut Microbiota on the Onset of Autoimmune Diseases Using TNFΔARE Murine Model. Microorganisms 2021;10:73. [PMID: 35056521 DOI: 10.3390/microorganisms10010073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zhang T, Wang T, Chen X, Zhao Z, Chen Z. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons. Exp Ther Med 2022;23:52. [PMID: 34934429 DOI: 10.3892/etm.2021.10974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Palacios-garcía I, Parada FJ. The holobiont mind: A bridge between 4E cognition and the microbiome. Adaptive Behavior. [DOI: 10.1177/10597123211053071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Roversi K, Callai-Silva N, Roversi K, Griffith M, Boutopoulos C, Prediger RD, Talbot S. Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain. Front Immunol 2021;12:759679. [PMID: 34868000 DOI: 10.3389/fimmu.2021.759679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomed Pharmacother 2022;145:112343. [PMID: 34864312 DOI: 10.1016/j.biopha.2021.112343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Jena R, Jain R, Muralidharan S, Yanamala VL, Zubair Z, Kantamaneni K, Jalla K, Renzu M, Alfonso M. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease. Cureus 2021;13:e19035. [PMID: 34853754 DOI: 10.7759/cureus.19035] [Reference Citation Analysis]
43 Liptak R, Gromova B, Gardlik R. Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders. Front Med (Lausanne) 2021;8:665520. [PMID: 34557498 DOI: 10.3389/fmed.2021.665520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Tanaka Y, Shimizu S, Shirotani M, Yorozu K, Kitamura K, Oehorumu M, Kawai Y, Fukuzawa Y. Nutrition and Cancer Risk from the Viewpoint of the Intestinal Microbiome. Nutrients 2021;13:3326. [PMID: 34684330 DOI: 10.3390/nu13103326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021;132:325-44. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
46 Hill AE, Wade-Martins R, Burnet PWJ. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease? Front Neurosci 2021;15:708587. [PMID: 34512244 DOI: 10.3389/fnins.2021.708587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ferrell JM, Chiang JY. Bile acid receptors and signaling crosstalk in the liver, gut and brain. Liver Research 2021;5:105-18. [DOI: 10.1016/j.livres.2021.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
48 Zhong HJ, Zeng HL, Cai YL, Zhuang YP, Liou YL, Wu Q, He XX. Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension. Front Cell Infect Microbiol 2021;11:679624. [PMID: 34458158 DOI: 10.3389/fcimb.2021.679624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
49 Wang H, Yang F, Zhang S, Xin R, Sun Y. Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis 2021;7:70. [PMID: 34381040 DOI: 10.1038/s41531-021-00213-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
50 Chen Y, Xu J, Chen Y. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients 2021;13:2099. [PMID: 34205336 DOI: 10.3390/nu13062099] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 22.5] [Reference Citation Analysis]
51 MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA. The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? Front Neurol 2021;12:666737. [PMID: 34122308 DOI: 10.3389/fneur.2021.666737] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
52 Gupta S, Mullish BH, Allegretti JR. Fecal Microbiota Transplantation: The Evolving Risk Landscape. Am J Gastroenterol 2021;116:647-56. [PMID: 33982930 DOI: 10.14309/ajg.0000000000001075] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
53 Schmidt EKA, Raposo PJF, Madsen KL, Fenrich KK, Kabarchuk G, Fouad K. What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis. Biology (Basel) 2021;10:254. [PMID: 33804928 DOI: 10.3390/biology10040254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ojeda J, Ávila A, Vidal PM. Gut Microbiota Interaction with the Central Nervous System throughout Life. J Clin Med 2021;10:1299. [PMID: 33801153 DOI: 10.3390/jcm10061299] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
55 Lorente-Picón M, Laguna A. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. Biomolecules 2021;11:433. [PMID: 33804226 DOI: 10.3390/biom11030433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
56 Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, Li XF, Gao BL. Association of Parkinson's Disease With Microbes and Microbiological Therapy. Front Cell Infect Microbiol 2021;11:619354. [PMID: 33763383 DOI: 10.3389/fcimb.2021.619354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
57 Fu P, Yung KKL. Response to Comment on "Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis". ACS Chem Neurosci 2021;12:811-2. [PMID: 33503369 DOI: 10.1021/acschemneuro.0c00718] [Reference Citation Analysis]
58 Jevans B, Di Monte DA. Spreading of alpha-synuclein pathology from the gut to the brain in Parkinson's disease. International Review of Movement Disorders 2021. [DOI: 10.1016/bs.irmvd.2021.08.004] [Reference Citation Analysis]
59 Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. Neurotherapeutics 2020;17:1406-17. [PMID: 33034846 DOI: 10.1007/s13311-020-00942-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]